[ Price : $8.95]
Regeneron Pharmaceuticals and AstraZeneca enter into a collaboration to research, develop and commercialize small molecule compoun...[ Price : $8.95]
King & Spalding attorneys analyze an FDA draft guidance on safety event analysis and reporting in IND and BE/BA studies.[ Price : $8.95]
FDA accepts for priority review an Aadi Bioscience NDA for its nanoparticle albumin-bound mTOR inhibitor Fyarro for treating advan...[ Price : $8.95]
FDA holds a Webinar to clarify agency thinking on the distinction between medical device servicing and remanufacturing and to cons...[ Price : $8.95]
Federal Register notice: FDA announces the rates for biosimilar user fees for fiscal year 2022.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Medical Device Reporting 21 CFR Part 803....[ Price : $8.95]
Federal Register notice: FDA announces the animal drug user fee rates and payment procedures for fiscal year 2022.[ Price : $8.95]
FDA asks Pfizer and Moderna to expand vaccine tests in children under age 11 to better understand the risk for heart muscle inflam...